View Older Stories View More Recent Stories

May 21, 2025 08:39AM Sarepta Therapeutics (SRPT) Gains 5pct on UK Dosing Update in ENVISION
May 21, 2025 08:31AM Sarepta Therapeutics (SRPT) Provides Update on UK Dosing in ENVISION Study of ELEVIDYS for the treatment of Duchenne Muscular Dystrophy
May 16, 2025 09:01AM Sarepta Therapeutics (SRPT) Shares New Protein Expression and Safety Results from ENDEAVOR in Participants 2 Years Old at Time of Treatment
May 13, 2025 10:58AM Morgan Stanley on Sarepta (SRPT): 'Elevidys Approval in Japan Further Confirms Favorable Benefit/Risk Profile'
May 13, 2025 09:25AM Sarepta Therapeutics (SRPT) Announces Approval in Japan of ELEVIDYS
May 8, 2025 06:30AM Evercore ISI Downgrades Sarepta Therapeutics (SRPT) to In Line, 'Near-Term Catalysts Won't Alleviate Key Concerns'
May 7, 2025 09:55AM Sarepta Therapeutics (SRPT) PT Slashed to $137 at TD Cowen
May 7, 2025 09:32AM Sarepta Therapeutics (SRPT) PT Lowered to $81 at Cantor Fitzgerald
May 7, 2025 09:31AM Sarepta Therapeutics (SRPT) PT Lowered to $58 at RBC Capital as 'Elevidys Hits A Wall'
May 7, 2025 09:14AM Sarepta Therapeutics (SRPT) PT Lowered to $120 at BMO Capital
May 7, 2025 07:16AM Sarepta Therapeutics (SRPT) PT Lowered to $40 at H.C. Wainwright
May 7, 2025 05:36AM Sarepta Therapeutics (SRPT) call put ratio 1 call to 1 put amid wide price movement
May 6, 2025 04:49PM After-hours movers: AMD, Marvell Tech, Super Micro Computer and more
May 6, 2025 04:19PM Sarepta Therapeutics (SRPT) Lowers Guidance
May 6, 2025 02:28PM Sarepta Therapeutics (SRPT) Weakness Tied to FDA Appointee
Apr 21, 2025 10:26AM Sarepta Therapeutics (SRPT) PT Slashed at Piper Sandler Following Survey Results
Apr 15, 2025 08:31AM Sarepta Therapeutics (SRPT) Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs
Apr 11, 2025 06:50AM Wells Fargo Starts Sarepta Therapeutics (SRPT) at Overweight 'on DMD Commercial Opportunities'
Apr 10, 2025 07:10AM Sarepta Therapeutics (SRPT) PT Lowered to $112 at Guggenheim
Apr 7, 2025 08:25AM Sarepta Therapeutics (SRPT) PT Lowered to $184 at Oppenheimer
Apr 7, 2025 06:40AM H.C. Wainwright Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
Apr 4, 2025 12:28PM Barclays Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)
Apr 4, 2025 08:44AM Sarepta Therapeutics (SRPT) Provides Update on ELEVIDYS
Apr 3, 2025 07:13AM Sarepta Therapeutics (SRPT) PT Lowered to $183 at Needham
Apr 2, 2025 06:37AM H.C. Wainwright Upgrades Sarepta Therapeutics (SRPT) to Neutral
Apr 1, 2025 10:00AM RBC makes changes to its flagship 'Top 30 Global Ideas for 2025' list
Mar 19, 2025 10:17AM UBS Reiterates Buy Rating on Sarepta Therapeutics (SRPT)
Mar 19, 2025 06:41AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
Mar 19, 2025 06:34AM Cantor Fitzgerald Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)
Mar 19, 2025 06:00AM Mizuho sees a compelling buying opportunity in this beaten-down biotech stock
Mar 18, 2025 10:25AM Leerink Defending Sarepta Therapeutics (SRPT): 'the stock reaction for SRPT is overdone'
Mar 18, 2025 09:51AM JPMorgan Comments on Sarepta Therapeutics (SRPT)
Mar 18, 2025 09:38AM TD Cowen Reiterates Buy Rating on Sarepta Therapeutics (SRPT) following Elevidys death
Mar 18, 2025 09:36AM Mizuho sees Sarepta Therapeutics (SRPT) sell-off on elevidys death 'likely an overreaction'
Mar 18, 2025 09:06AM BofA Defending Sarepta Therapeutics (SRPT): 'Risk-benefit profile of Elevidys remains favorable despite death report'
Mar 18, 2025 08:02AM Sarepta Therapeutics (SRPT) Shares Safety Update on ELEVIDYS
Mar 18, 2025 07:40AM Sarepta Therapeutics (SRPT) Plunges 20% Pre-Open, Reason For Drop Unclear
Mar 7, 2025 07:13AM Scotiabank Starts Sarepta Therapeutics (SRPT) at Sector Perform
Mar 4, 2025 09:17AM Cantor Fitzgerald Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)
Mar 3, 2025 04:04PM Sarepta Therapeutics (SRPT) files mixed shelf
Feb 27, 2025 08:47AM RBC on Sarepta Therapeutics (SRPT): 'Overall We View Shares as Fundamentally Undervalued'; PT Lowered
Feb 27, 2025 05:31AM Sarepta Therapeutics (SRPT) PT Lowered to $190 at Mizuho
Feb 26, 2025 04:24PM Sarepta Therapeutics (SRPT) Tops Q4 EPS by 36c
Feb 11, 2025 04:16AM Deutsche Bank Starts Sarepta Therapeutics (SRPT) at Hold
Feb 10, 2025 08:31AM Arrowhead Pharmaceuticals (ARWR) Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics (SRPT)
Jan 28, 2025 08:32AM BMO Capital Reiterates Outperform on Sarepta Therapeutics (SRPT) Following Part-2 Data from Elevidys PhIII
Jan 27, 2025 12:54PM Morgan Stanley Reiterates Overweight Rating on Sarepta Therapeutics (SRPT)
Jan 27, 2025 12:53PM Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
Jan 15, 2025 06:39AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
Jan 14, 2025 10:10AM Piper Sandler on Sarepta Therapeutics (SRPT): 'SRPT Outperforms Revenue Guidance Driven By Elevidys'
View More Recent Stories View Older Stories